INOVIO PHARMACEUTICALS, INC. Increase (Decrease) in Other Operating Liabilities
INOVIO PHARMACEUTICALS, INC. (INO) reported Increase (Decrease) in Other Operating Liabilities of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2024-03-06
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in other operating liabilities for the quarter ending 2023-12-31 was $0.00.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in other operating liabilities for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in other operating liabilities for the quarter ending 2023-06-30 was $0.00.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in other operating liabilities for the quarter ending 2023-03-31 was $0.00.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in other operating liabilities for fiscal 2023 was $0.00.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in other operating liabilities for fiscal 2022 was -$14.83K.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in other operating liabilities for fiscal 2021 was -$42.84K, a 306.74% decline from fiscal 2020.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in other operating liabilities for fiscal 2020 was $20.72K.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $0.00 derived: sum of 2 quarters · filed 2024-03-06 | $0.00 derived: sum of 3 quarters · filed 2024-03-06 | $0.00 10-K · filed 2024-03-06 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | -$710.35K derived: sum of 4 quarters · filed 2024-03-06 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | -$710.35K derived: sum of 3 quarters · filed 2024-03-06 | $0.00 derived: sum of 4 quarters · filed 2024-03-06 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-10 | -$710.35K derived: sum of 2 quarters · filed 2024-03-06 | $0.00 derived: sum of 3 quarters · filed 2024-03-06 | $0.00 derived: sum of 4 quarters · filed 2024-03-06 |
| 2022-12-31 | -$710.35K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $0.00 derived: sum of 2 quarters · filed 2024-03-06 | $0.00 derived: sum of 3 quarters · filed 2024-03-06 | -$14.83K 10-K · filed 2024-03-06 |
| 2022-09-30 | $710.35K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $710.35K derived: sum of 2 quarters · filed 2023-11-09 | $695.52K 10-Q · filed 2023-11-09 | $646.21K derived: sum of 4 quarters · filed 2024-03-06 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$14.83K 10-Q · filed 2023-08-09 | -$64.14K derived: sum of 3 quarters · filed 2024-03-06 | -$64.14K derived: sum of 4 quarters · filed 2024-03-06 |
| 2022-03-31 | -$14.83K 10-Q · filed 2023-05-10 | -$64.14K derived: sum of 2 quarters · filed 2024-03-06 | -$64.14K derived: sum of 3 quarters · filed 2024-03-06 | -$64.14K derived: sum of 4 quarters · filed 2024-03-06 |
| 2021-12-31 | -$49.31K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | -$49.31K derived: sum of 2 quarters · filed 2024-03-06 | -$49.31K derived: sum of 3 quarters · filed 2024-03-06 | -$42.84K 10-K · filed 2024-03-06 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $6.48K 10-Q · filed 2022-11-08 | $24.36K derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $6.48K 10-Q · filed 2022-08-09 | $24.36K derived: sum of 3 quarters · filed 2023-03-01 | -$2.49K derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $6.48K 10-Q · filed 2022-05-10 | $24.36K derived: sum of 2 quarters · filed 2023-03-01 | -$2.49K derived: sum of 3 quarters · filed 2023-03-01 | -$9.30K derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $17.89K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$8.97K derived: sum of 2 quarters · filed 2023-03-01 | -$15.78K derived: sum of 3 quarters · filed 2023-03-01 | $20.72K 10-K · filed 2023-03-01 |
| 2020-09-30 | -$26.85K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$33.67K derived: sum of 2 quarters · filed 2021-11-09 | $2.83K 10-Q · filed 2021-11-09 | -$10.57K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | -$6.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $29.69K 10-Q · filed 2021-08-09 | $16.29K derived: sum of 3 quarters · filed 2022-03-01 | $15.87K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $36.50K 10-Q · filed 2021-05-10 | $23.10K derived: sum of 2 quarters · filed 2022-03-01 | $22.68K derived: sum of 3 quarters · filed 2022-03-01 | $11.07K derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | -$13.40K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$13.82K derived: sum of 2 quarters · filed 2022-03-01 | -$25.43K derived: sum of 3 quarters · filed 2022-03-01 | -$48.51K 10-K · filed 2022-03-01 |
| 2019-09-30 | -$419.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$12.03K derived: sum of 2 quarters · filed 2020-11-09 | -$35.11K 10-Q · filed 2020-11-09 | -$47.44K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | -$11.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$34.69K 10-Q · filed 2020-08-10 | -$47.02K derived: sum of 3 quarters · filed 2021-03-01 | $52.65K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | -$23.08K 10-Q · filed 2020-05-11 | -$35.41K derived: sum of 2 quarters · filed 2021-03-01 | $64.26K derived: sum of 3 quarters · filed 2021-03-01 | -$197.07K derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | -$12.34K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $87.33K derived: sum of 2 quarters · filed 2021-03-01 | -$173.99K derived: sum of 3 quarters · filed 2021-03-01 | $87.33K 10-K · filed 2021-03-01 |
| 2018-09-30 | $99.67K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$161.66K derived: sum of 2 quarters · filed 2019-11-12 | $99.67K 10-Q · filed 2019-11-12 | $99.67K derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | -$261.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $0.00 10-Q · filed 2019-08-08 | $0.00 derived: sum of 3 quarters · filed 2020-03-12 | |
| 2018-03-31 | $261.32K 10-Q · filed 2019-05-09 | $261.32K derived: sum of 2 quarters · filed 2020-03-12 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $0.00 10-K · filed 2020-03-12 | ||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-08 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |